相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。Patient-reported outcomes (PRO) focused on adverse events (PRO-AEs) in adjuvant and metastatic breast cancer: clinical and translational implications
Stefan Stefanovic et al.
SUPPORTIVE CARE IN CANCER (2017)
Ablative Therapies in Metastatic Breast Cancer: A Systematic Review
Michael Jonathan Kucharczyk et al.
BREAST CANCER RESEARCH AND TREATMENT (2017)
Electronic-Based Patient-Reported Outcomes: Willingness, Needs, and Barriers in Adjuvant and Metastatic Breast Cancer Patients
Andreas D. Hartkopf et al.
JMIR CANCER (2017)
Health-related Quality of Life in Metastatic and Adjuvant Breast Cancer Patients
M. Wallwiener et al.
GEBURTSHILFE UND FRAUENHEILKUNDE (2016)
Willingness of Patients with Breast Cancer in the Adjuvant and Metastatic Setting to Use Electronic Surveys (ePRO) Depends on Sociodemographic Factors, Health-related Quality of Life, Disease Status and Computer Skills
J. Graf et al.
GEBURTSHILFE UND FRAUENHEILKUNDE (2016)
Ribociclib as First-Line Therapy for HR-Positive, Advanced Breast Cancer
G. N. Hortobagyi et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Palbociclib and Letrozole in Advanced Breast Cancer
Richard S. Finn et al.
NEW ENGLAND JOURNAL OF MEDICINE (2016)
Electronic real-time assessment of patient-reported outcomes in routine care first findings and experiences from the implementation in a comprehensive cancer center
Freya Trautmann et al.
SUPPORTIVE CARE IN CANCER (2016)
The Electronic Patient Reported Outcome Tool: Testing Usability and Feasibility of a Mobile App and Portal to Support Care for Patients With Complex Chronic Disease and Disability in Primary Care Settings
Carolyn Steele Gray et al.
JMIR MHEALTH AND UHEALTH (2016)
Reliability and Validity of Amharic Version of EORTC QLQ-C 30 Questionnaire among Gynecological Cancer Patients in Ethiopia
Birhanu Abera Ayana et al.
PLOS ONE (2016)
Overall survival (OS) endpoint: an incomplete evaluation of metastatic breast cancer (MBC) treatment outcome
Jacques Raphael et al.
BREAST CANCER RESEARCH AND TREATMENT (2015)
Retrospective analysis of metastatic behaviour of breast cancer subtypes
C. Dilara Savci-Heijink et al.
BREAST CANCER RESEARCH AND TREATMENT (2015)
eHealth in modern breast cancer treatment: New possibilities in communication between patients, doctors and nursing staff
Rachel Wuerstlein et al.
CANCER RESEARCH (2015)
The cyclin-dependent kinase 4/6 inhibitor palbociclib in combination with letrozole versus letrozole alone as first-line treatment of oestrogen receptor-positive, HER2-negative, advanced breast cancer (PALOMA-1/TRIO-18): a randomised phase 2 study
Richard S. Finn et al.
LANCET ONCOLOGY (2015)
Assessing the need for psychooncological support: screening instruments in combination with patients' subjective evaluation may define psychooncological pathways
N. Schaeffeler et al.
PSYCHO-ONCOLOGY (2015)
New Frontiers in Patient-Reported Outcomes: Adverse Event Reporting, Comparative Effectiveness, and Quality Assessment
Ethan Basch
ANNUAL REVIEW OF MEDICINE, VOL 65 (2014)
Tablet, Web-Based, or Paper Questionnaires for Measuring Anxiety in Patients Suspected of Breast Cancer: Patients' Preferences and Quality of Collected Data
Maarten W. Barentsz et al.
JOURNAL OF MEDICAL INTERNET RESEARCH (2014)
Health-related quality-of-life assessment in CLEOPATRA, a phase III study combining pertuzumab with trastuzumab and docetaxel in metastatic breast cancer
J. Cortes et al.
ANNALS OF ONCOLOGY (2013)
Quality of life during chemotherapy in lung cancer patients: results across different treatment lines
L. M. Wintner et al.
BRITISH JOURNAL OF CANCER (2013)
Feasibility of Long-Term Patient Self-Reporting of Toxicities From Home via the Internet During Routine Chemotherapy
Timothy J. Judson et al.
JOURNAL OF CLINICAL ONCOLOGY (2013)
Patient-reported Outcomes (PROs) Putting the Patient Perspective in Patient-centered Outcomes Research
Claire F. Snyder et al.
MEDICAL CARE (2013)
Everolimus in Postmenopausal Hormone-Receptor-Positive Advanced Breast Cancer
Jose Baselga et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Trastuzumab Emtansine for HER2-Positive Advanced Breast Cancer
Sunil Verma et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Pertuzumab plus Trastuzumab plus Docetaxel for Metastatic Breast Cancer
Jose Baselga et al.
NEW ENGLAND JOURNAL OF MEDICINE (2012)
Patient-reported outcomes in drug safety evaluation
E. Basch
ANNALS OF ONCOLOGY (2009)
Survival Outcomes for Patients with Metastatic Triple-Negative Breast Cancer: Implications for Clinical Practice and Trial Design
Farrah Kassam et al.
CLINICAL BREAST CANCER (2009)
Feasibility and Acceptability to Patients of a Longitudinal System for Evaluating Cancer-Related Symptoms and Quality of Life: Pilot Study of an e/Tablet Data-Collection System in Academic Oncology
Amy P. Abernethy et al.
JOURNAL OF PAIN AND SYMPTOM MANAGEMENT (2009)
Adverse Symptom Event Reporting by Patients vs Clinicians: Relationships With Clinical Outcomes
Ethan Basch et al.
JNCI-JOURNAL OF THE NATIONAL CANCER INSTITUTE (2009)
Patient reported outcome measures: a model-based classification system for research and clinical practice
Jose M. Valderas et al.
QUALITY OF LIFE RESEARCH (2008)
Impact of chemotherapy beyond the first line in patients with metastatic breast cancer
Armelle Dufresne et al.
BREAST CANCER RESEARCH AND TREATMENT (2008)
Long-term toxicity monitoring via electronic patient-reported outcomes in patients receiving chemotherapy
Ethan Basch et al.
JOURNAL OF CLINICAL ONCOLOGY (2007)
Quality of life in metastatic breast cancer patients under chemotherapy or supportive care: a single-institution comparative study
M. V. Karamouzis et al.
EUROPEAN JOURNAL OF CANCER CARE (2007)
Health-related quality of life and other patient-reported outcomes in the European centralized drug regulatory process: A review of guidance documents and performed authorizations of medicinal products 1995 to 2003
A Szende et al.
VALUE IN HEALTH (2005)
Measuring quality of life in routine oncology practice improves communication and patient well-being: A randomized controlled trial
G Velikova et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
Measuring treatment impact: a review of patient-reported outcomes and other efficacy endpoints in approved product labels
RJ Willke et al.
CONTROLLED CLINICAL TRIALS (2004)
Health-related quality of life and psychosocial status in breast cancer prognosis: Analysis of multiple variables
PJ Goodwin et al.
JOURNAL OF CLINICAL ONCOLOGY (2004)
Differences in quality of life domains and psychopathologic and psychosocial factors in psychiatric patients
M Ritsner et al.
JOURNAL OF CLINICAL PSYCHIATRY (2000)